OAM
IART icon

Oppenheimer Asset Management’s Integra LifeSciences IART Stock Holding History

Oppenheimer Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,212
Closed -$54K – 1240
2020
Q1 		$54K Buy
+1,212
New +$63.6K ﹤0.01% 1245

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Oppenheimer Asset Management's IART Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Integra LifeSciences (IART) in Q2 2020, closing a stake of 1,212 shares — an estimated $54K sold.

Oppenheimer Asset Management first reported a position in IART in Q1 2020 and held it in 1 quarter. The position peaked at $54K in Q1 2020. 264 funds tracked by Wall St. Rank hold IART as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining Integra LifeSciences position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 1,212 Integra LifeSciences shares in Q2 2020, an estimated $54K.
  • Oppenheimer Asset Management first reported a position in Integra LifeSciences in Q1 2020 and held it in 1 quarter.
  • Oppenheimer Asset Management's Integra LifeSciences position peaked at $54K in Q1 2020.
  • 264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.